Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v6-EN
Language English English
Date Updated 2021-09-09 2021-09-09
Drug Identification Number 02145766 02145766
Brand name VISIPAQUE 270 VISIPAQUE 270
Common or Proper name Iodixanol injection USP Iodixanol injection USP
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients IODIXANOL IODIXANOL
Strength(s) 550MG 550MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS
Packaging size 50 mL 50 mL
ATC code V08AB V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2021-09-03 2021-09-03
Actual start date 2021-09-03 2021-09-03
Estimated end date 2021-09-09 2021-09-09
Actual end date 2021-09-08 2021-09-08
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments